The American Cancer Society bestowed its highest accolade, the Medal of Honor, on Jennifer Doudna, a faculty scientist in Molecular Biophysics and Integrated Bioimaging (MBIB), and four others during an October 18 ceremony in Washington, D.C. The medal is awarded to distinguished individuals who have made valuable contributions in the fight against cancer through basic research, clinical research, or public health interventions.
Doudna, a Howard Hughes Medical Institute (HHMI) investigator and professor of molecular and cell biology and of chemistry at UC Berkeley, and Emmanuelle Charpentier of the Max Planck Institute for Infection Biology in Berlin were honored for their invention of the gene-editing tool CRISPR-Cas9, which has transformed basic cancer research and spawned new cancer therapies currently undergoing trials.
Read more from UC Berkeley News.
